Companies in #Acute Surgical Pain
Found 1 company operating in this sector.
Dogwood Therapeutics (formerly Virios Therapeutics, renamed October 2024) is a development-stage biotechnology company focused on first-in-class, non-opioid medicines for pain and fatigue-related disorders. Its lead candidate, Halneuron, is a highly selective sodium channel blocker in Phase 2b development for chemotherapy-induced neuropathic pain (CINP) and cancer pain, with a 12-week open-label follow-on study commenced in May 2026; IMC-1 (famciclovir + celecoxib) completed a Phase 2b trial in fibromyalgia. Founded in 2012 and headquartered in Alpharetta, Georgia.